Phosphorylation of 2',3'-dideoxyinosine by cytosolic 5'-nucleotidase of human lymphoid cells

MA Johnson and A Fridland

Department of Biochemical and Clinical Pharmacology, St. Jude Children's Research Hospital, Memphis, Tennessee 38101.

2',3'-Dideoxyinosine (ddlno) is a potent and selective inhibitor of human immunodeficiency virus in human lymphoid cells and monocytes/macrophages. Earlier studies [J. Biol. Chem. 263:15354 (1988)] showed that anabolism of ddlno in human lymphoid cells is mediated via an initial step of phosphorylation and subsequent amination to dideoxy-AMP via adenylosuccinate synthetase/lyase. Evidence was obtained that neither adenosine kinase nor deoxycytidine kinase is involved in the phosphorylation of this compound in human lymphoid cells. We now find that, in the presence of MgCl2, KCl, and inosine-5'-monophosphate as phosphate donor, purified cytosolic 5'- nucleotidase catalyzed the phosphorylation of ddlno. Although not phosphate donors, ATP, diadenosine tetraphosphate, and glycerate-2,3- bisphosphate stimulate this phosphorylation by the nucleotidase 4-5- fold. In addition to ddlno, the antiviral nucleoside analogs 2',3'- dideoxyguanosine and carbovir were substrates for this enzyme. The relative phosphorylation of these compounds varied with the concentration of the phosphate donor IMP. Approximate Km values of the nucleotidase for inosine, ddlno, dideoxyguanosine, and carbovir were, respectively, 3.4, 0.5, 0.9, and 1.7 mM. Although the substrate activity of dideoxynucleosides is inefficient, it appears likely that this nucleotidase is responsible for the metabolism of these compounds to their active nucleotides, yielding antiviral activity in human lymphoid cells.

Volume 36, Issue 2, pp. 291-295, 08/01/1989
Copyright © 1989 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				K. Wallden, P. Stenmark, T. Nyman, S. Flodin, S. Graslund, P. Loppnau, V. Bianchi, and P. Nordlund Crystal Structure of Human Cytosolic 5'-Nucleotidase II: INSIGHTS INTO ALLOSTERIC REGULATION AND SUBSTRATE RECOGNITION J. Biol. Chem., June 15, 2007; 282(24): 17828 - 17836. [Abstract] [Full Text] [PDF]

				S. Aquaro, V. Svicher, D. Schols, M. Pollicita, A. Antinori, J. Balzarini, and C. F. Perno Mechanisms underlying activity of antiretroviral drugs in HIV-1-infected macrophages: new therapeutic strategies J. Leukoc. Biol., November 1, 2006; 80(5): 1103 - 1110. [Abstract] [Full Text] [PDF]

				A. S. Ray, B. I. Hernandez-Santiago, J. S. Mathew, E. Murakami, C. Bozeman, M.-Y. Xie, G. E. Dutschman, E. Gullen, Z. Yang, S. Hurwitz, et al. Mechanism of Anti-Human Immunodeficiency Virus Activity of {beta}-D-6-Cyclopropylamino-2',3'-Didehydro-2',3'-Dideoxyguanosine Antimicrob. Agents Chemother., May 1, 2005; 49(5): 1994 - 2001. [Abstract] [Full Text] [PDF]

				V. Bianchi and J. Spychala Mammalian 5'-Nucleotidases J. Biol. Chem., November 21, 2003; 278(47): 46195 - 46198. [Full Text] [PDF]

				G. Reid, P. Wielinga, N. Zelcer, M. de Haas, L. van Deemter, J. Wijnholds, J. Balzarini, and P. Borst Characterization of the Transport of Nucleoside Analog Drugs by the Human Multidrug Resistance Proteins MRP4 and MRP5 Mol. Pharmacol., May 1, 2003; 63(5): 1094 - 1103. [Abstract] [Full Text] [PDF]

				H. Gourdeau, M. L. Clarke, F. Ouellet, D. Mowles, M. Selner, A. Richard, N. Lee, J. R. Mackey, J. D. Young, J. Jolivet, et al. Mechanisms of Uptake and Resistance to Troxacitabine, a Novel Deoxycytidine Nucleoside Analogue, in Human Leukemic and Solid Tumor Cell Lines Cancer Res., October 1, 2001; 61(19): 7217 - 7224. [Abstract] [Full Text] [PDF]

				J. Balzarini, S. Aquaro, T. Knispel, C. Rampazzo, V. Bianchi, C.-F. Perno, E. De Clercq, and C. Meier Cyclosaligenyl-2',3'-didehydro-2',3'-dideoxythymidine Monophosphate: Efficient Intracellular Delivery of d4TMP Mol. Pharmacol., November 1, 2000; 58(5): 928 - 935. [Abstract] [Full Text]

				L. Placidi, E. Cretton-Scott, G. Gosselin, C. Pierra, R. F. Schinazi, J.-L. Imbach, M. H. el Kouni, and J.-P. Sommadossi Intracellular Metabolism of beta -L-2',3'-Dideoxyadenosine: Relevance to Its Limited Antiviral Activity Antimicrob. Agents Chemother., April 1, 2000; 44(4): 853 - 858. [Abstract] [Full Text]

				J. Balzarini, L. Naesens, S. Aquaro, T. Knispel, C.-F. Perno, E. De Clercq, and C. Meier Intracellular Metabolism of CycloSaligenyl 3'-Azido-2',3'-dideoxythymidine Monophosphate, a Prodrug of 3'-Azido-2',3'-dideoxythymidine (Zidovudine) Mol. Pharmacol., December 1, 1999; 56(6): 1354 - 1361. [Abstract] [Full Text]

				J.-M. de Muys, H. Gourdeau, N. Nguyen-Ba, D. L. Taylor, P. S. Ahmed, T. Mansour, C. Locas, N. Richard, M. A. Wainberg, and R. F. Rando Anti-Human Immunodeficiency Virus Type 1 Activity, Intracellular Metabolism, and Pharmacokinetic Evaluation of 2'-Deoxy-3'-Oxa-4'-Thiocytidine Antimicrob. Agents Chemother., August 1, 1999; 43(8): 1835 - 1844. [Abstract] [Full Text]

				L. L. Bennett Jr., P. W. Allan, G. Arnett, Y. F. Shealy, D. S. Shewach, W. S. Mason, I. Fourel, and W. B. Parker Metabolism in Human Cells of the D and L Enantiomers of the Carbocyclic Analog of 2'-Deoxyguanosine: Substrate Activity with Deoxycytidine Kinase, Mitochondrial Deoxyguanosine Kinase, and 5'-Nucleotidase Antimicrob. Agents Chemother., May 1, 1998; 42(5): 1045 - 1051. [Abstract] [Full Text]

				S.-H. Liu, K. L. Grove, and Y.-C. Cheng Unique Metabolism of a Novel Antiviral L-Nucleoside Analog, 2'-Fluoro-5-Methyl-beta -L-Arabinofuranosyluracil: a Substrate for Both Thymidine Kinase and Deoxycytidine Kinase Antimicrob. Agents Chemother., April 1, 1998; 42(4): 833 - 839. [Abstract] [Full Text]

				H Mitsuya, R Yarchoan, and S Broder Molecular targets for AIDS therapy Science, September 28, 1990; 249(4976): 1533 - 1544. [Abstract] [PDF]